The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.

MJ Crawford; VC Leeson; R Evans; B Barrett; A McQuaid; J Cheshire; R Sanatinia; G Lamph; P Sen; K Anagnostakis; L Millard; I Qurashi; F Larkin; S Gibbon

doi:10.1177/20451253221090832

The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.

MJ Crawford, VC Leeson, R Evans, B Barrett, A McQuaid, J Cheshire, R Sanatinia, G Lamph, P Sen, K Anagnostakis, L Millard, I Qurashi, F Larkin, S Gibbon

Nursing & Midwifery

Research output: Contribution to journal › Article (journal) › peer-review

3 Citations (Scopus)

27 Downloads (Pure)

Abstract

Data from case series suggest that clozapine may benefit inpatients with borderline personality disorder (BPD), but randomised trials have not been conducted.

Original language	English
Journal	Therapeutic Advances in Psychopharmacology
Volume	12
DOIs	https://doi.org/10.1177/20451253221090832
Publication status	Published - 29 Apr 2022

Access to Document

10.1177/20451253221090832

20451253221090832Final published version, 690 KBLicence: CC BY

Cite this

Crawford, MJ., Leeson, VC., Evans, R., Barrett, B., McQuaid, A., Cheshire, J., Sanatinia, R., Lamph, G., Sen, P., Anagnostakis, K., Millard, L., Qurashi, I., Larkin, F., & Gibbon, S. (2022). The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial. Therapeutic Advances in Psychopharmacology, 12. https://doi.org/10.1177/20451253221090832

@article{6b9bfac7166b4ae2bafe6e14b097f912,

title = "The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.",

abstract = "Data from case series suggest that clozapine may benefit inpatients with borderline personality disorder (BPD), but randomised trials have not been conducted.",

author = "MJ Crawford and VC Leeson and R Evans and B Barrett and A McQuaid and J Cheshire and R Sanatinia and G Lamph and P Sen and K Anagnostakis and L Millard and I Qurashi and F Larkin and S Gibbon",

year = "2022",

month = apr,

day = "29",

doi = "10.1177/20451253221090832",

language = "English",

volume = "12",

journal = "Therapeutic Advances in Psychopharmacology",

issn = "2045-1261",

publisher = "Sage Publications",

}

Crawford, MJ, Leeson, VC, Evans, R, Barrett, B, McQuaid, A, Cheshire, J, Sanatinia, R, Lamph, G, Sen, P, Anagnostakis, K, Millard, L, Qurashi, I, Larkin, F & Gibbon, S 2022, 'The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.', Therapeutic Advances in Psychopharmacology, vol. 12. https://doi.org/10.1177/20451253221090832

TY - JOUR

T1 - The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.

AU - Crawford, MJ

AU - Leeson, VC

AU - Evans, R

AU - Barrett, B

AU - McQuaid, A

AU - Cheshire, J

AU - Sanatinia, R

AU - Lamph, G

AU - Sen, P

AU - Anagnostakis, K

AU - Millard, L

AU - Qurashi, I

AU - Larkin, F

AU - Gibbon, S

PY - 2022/4/29

Y1 - 2022/4/29

N2 - Data from case series suggest that clozapine may benefit inpatients with borderline personality disorder (BPD), but randomised trials have not been conducted.

AB - Data from case series suggest that clozapine may benefit inpatients with borderline personality disorder (BPD), but randomised trials have not been conducted.

UR - http://europepmc.org/abstract/med/35510087

U2 - 10.1177/20451253221090832

DO - 10.1177/20451253221090832

M3 - Article (journal)

C2 - 35510087

SN - 2045-1261

VL - 12

JO - Therapeutic Advances in Psychopharmacology

JF - Therapeutic Advances in Psychopharmacology

ER -

The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this